Leading brokers name 3 ASX shares to sell today

The bears are claiming that investors would be better off selling these ASX shares…

| More on:
Model bear in front of falling line graph, cheap stocks, cheap ASX shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday I looked at three ASX shares that brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on these ASX shares:

A2 Milk Company Ltd (ASX: A2M)

According to a note out of Credit Suisse, its analysts have retained their underperform rating and $5.00 price target on this infant formula company's shares. The broker notes that the Chinese government is aiming to boost its birth rate by allowing couples to have three children now. While this could be a boost to demand for infant formula, the broker appears to believe it's too soon to get excited. Especially as it was already factoring in an increase in China's birth rate next year due to a catch up from a slowdown during the pandemic. The a2 Milk share price is trading at $5.70 on Tuesday.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

A note out of UBS reveals that its analysts have retained their sell rating and cut the price target on this medical device company's shares to NZ$22.65 (A$21.25). According to the note, the broker is expecting a sharp decline in profits from Fisher & Paykel Healthcare in FY 2022 after having its recent FY 2021 results boosted by pandemic-driven demand for ventilators. In light of this, it sees its shares as overvalued and fears they could come under pressure as investors shift away from COVID winners. The Fisher & Paykel Healthcare share price is trading at A$27.81 today.

Fortescue Metals Group Limited (ASX: FMG)

Analysts at Morgan Stanley have retained their underweight rating and $17.45 price target on this iron ore producer's shares. This follows the release of an update on its Iron Bridge project earlier this week. That update revealed that its capital estimate has been revised higher to US$3.3 billion to US$3.5 billion. Morgan Stanley believes these revisions could weigh on the project's valuation. It also sees risks to low grade iron ore discounting increasing meaningfully. The Fortescue share price is trading at $22.88 today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A colourfully dressed young skydiver wearing heavy gold gloves smiles and gives a thumbs up as he falls through the sky.
Broker Notes

Bell Potter says this ASX silver stock has 'a sky full of upside'

This exciting stock could be a high risk, high reward pick according to the broker.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Broker Notes

These 2 ASX All Ords shares tripled in value last year. Can they keep going?

Both of these ASX shares more than tripled their market capitalisations in 2025.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Morgans says these ASX 200 shares can rise 20%+

The broker says these shares could offer major upside.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Broker Notes

Brokers rate 2 ASX All Ords rippers of 2025: Is their phenomenal run over?

Both of these ASX shares more than tripled in value last year.

Read more »

a woman puts her hand to her chin and looks to the side deep in thought as though pondering something significant.
Broker Notes

2 ASX 200 gold shares to buy and 1 to sell: experts

After exceptional share price growth for 2 years, experts say investors need to choose their gold stocks carefully.

Read more »